Analyst Ratings for Pharmasset (VRUS) [Neutrals]
VRUS Rating Summary
VRUS Price Target Summary
- Highest: $138.00 (Wells Fargo)
- Lowest: $90.00 (Piper Jaffray)
- Average: $129.00
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$129.00 (-5.8%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/19/2011 | William Blair | Downgrade | Market Perform (N/A) |
N/A (N/A) |
123.75 | 136.97 | 10.68% | Details |
| 12/16/2011 | Baird | Downgrade | Neutral (N/A) |
137.00 (N/A) |
127.79 | 136.97 | 7.18% | Details |
| 11/28/2011 | Credit Suisse | Downgrade | Neutral (N/A) |
N/A (N/A) |
133.17 | 136.97 | 2.85% | Details |
| 11/22/2011 | Brean Capital | Downgrade | Hold (N/A) |
N/A (N/A) |
134.14 | 136.97 | 2.11% | Details |
| 11/22/2011 | Canaccord Genuity | Downgrade | Hold (N/A) |
137.00 (N/A) |
134.14 | 136.97 | 2.11% | Details |
| 11/22/2011 | UBS | Downgrade | Neutral (N/A) |
N/A (N/A) |
134.14 | 136.97 | 2.11% | Details |
| 11/22/2011 | Leerink Swann | Downgrade | Market Perform (N/A) |
137.00 (N/A) |
134.14 | 136.97 | 2.11% | Details |
| 11/22/2011 | Wells Fargo | Downgrade | Market Perform (N/A) |
138.00 (N/A) |
134.14 | 136.97 | 2.11% | Details |
| 11/4/2011 | JMP Securities | Downgrade | Market Perform (N/A) |
N/A (N/A) |
73.50 | 136.97 | 86.35% | Details |
| 2/8/2011 | Goldman Sachs | New Coverage | Neutral (N/A) |
N/A (N/A) |
49.33 | 136.97 | 177.66% | Details |
